Ipsen logo

Ipsen

Senior Medical Director, Global Medical Affairs – Neurosciences (Migraine Lead)
LondonPermanentHybridFull-TimeLead

Posted 3 weeks ago

Description

About Ipsen
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

About the Role
The Senior Medical Director, Global Medical Affairs leads the global medical strategy for Ipsen’s Neurosciences portfolio with a primary focus on the launch and lifecycle management of the Migraine indication.

You will provide senior medical leadership, scientific expertise and strategic direction to ensure successful product launch, evidence generation and external engagement. And serve as the principal medical expert for Migraine, shaping Ipsen’s position in the therapeutic area and driving cross-functional alignment to achieve business and patient outcomes.

Main Responsibilities
Medical Strategy & Evidence Generation
  • Lead the development and execution of the global medical strategy for Migraine, ensuring alignment with brand objectives and launch excellence.
  • Oversee the design and implementation of clinical and real-world evidence generation plans specific to Migraine, including pivotal trials, registries, and investigator-initiated/sponsored studies.
  • Ensure robust scientific communication of Migraine data to internal and external stakeholders.

Cross-Functional Leadership
  • Chair cross-functional launch teams for Migraine, collaborating with Commercial, Market Access, Regulatory, and R&D.
  • Drive the development of medical education, publication planning, and KOL engagement strategies tailored to Migraine.

External Engagement & Thought Leadership
  • Represent Ipsen at international Migraine congresses, advisory boards, and scientific forums.
  • Build and maintain strategic partnerships with global Migraine experts, academic institutions, and patient advocacy groups.

Lifecycle Management & Launch Excellence
  • Provide senior medical input into lifecycle management and post-launch activities for Migraine.
  • Anticipate and address emerging scientific, clinical, and market trends in Migraine.

Qualifications
  • Medical degree (MD) or advanced degree in a relevant scientific field (PhD, PharmD).
  • Extensive experience in medical affairs, with a proven track record in global product launches (preferably in Migraine or neurology).
  • Deep understanding of Migraine pathophysiology, treatment landscape, and unmet needs.
  • Demonstrated leadership of cross-functional and multicultural teams.
  • Strong network with Migraine KOLs and scientific societies.
  • Experience in real-world evidence generation and health economics for Migraine.
  • English fluency

Ipsen is committed to fostering a diverse and inclusive workplace where all employees feel valued and empowered. We are committed to creating a workplace where everyone feels heard, valued, and supported; where we embrace “The Real Us”. The value we place on different perspectives and experiences drives our commitment to inclusion and equal opportunities.
Ipsen cover
Ipsen logo

Ipsen

Transforming lives through targeted medicines in oncology, rare disease and neuroscience

Boulogne-BillancourtPharmaceuticals1000+
Ipsen logo

Ipsen

Pharmaceuticals

Join a global biopharmaceutical company where your work directly impacts patients facing the most challenging medical conditions, backed by nearly 100 years of scientific innovation and a pipeline focused on breakthrough therapies.